Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of levonorgestrel vaginal delivery system dose strengths versus desogestrel for ovulation inhibition
2019-002350-22Phase 2Completed
- Sponsor
- Chemo
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of avatrombopag and desogestrel in contraception (4 arms), sponsored by Chemo. Primary endpoint: Inhibition of ovulation. Started Jul 2019; status: completed.
02
Drugs
avatrombopagdesogestrel
03
Conditions
contraception
Beyond the preview
Go deeper on 2019-002350-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002350-22.